X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11457) 11457
Publication (907) 907
Book Review (75) 75
Book Chapter (34) 34
Dissertation (4) 4
Magazine Article (4) 4
Book / eBook (3) 3
Conference Proceeding (2) 2
Government Document (1) 1
Presentation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10387) 10387
female (7356) 7356
male (6787) 6787
remission induction (6237) 6237
middle aged (6032) 6032
adult (5471) 5471
oncology (5422) 5422
index medicus (5333) 5333
aged (4777) 4777
antineoplastic combined chemotherapy protocols - therapeutic use (4573) 4573
chemotherapy (3428) 3428
treatment outcome (3285) 3285
antineoplastic combined chemotherapy protocols - adverse effects (3257) 3257
hematology (3154) 3154
cancer (2890) 2890
adolescent (2054) 2054
induction (1950) 1950
induction chemotherapy (1728) 1728
therapy (1678) 1678
survival rate (1673) 1673
combined modality therapy (1607) 1607
disease-free survival (1586) 1586
prognosis (1469) 1469
aged, 80 and over (1451) 1451
care and treatment (1411) 1411
follow-up studies (1368) 1368
retrospective studies (1339) 1339
neoplasm staging (1333) 1333
survival analysis (1257) 1257
child (1237) 1237
drug administration schedule (1211) 1211
antineoplastic combined chemotherapy protocols - administration & dosage (1101) 1101
cisplatin - administration & dosage (1073) 1073
antineoplastic agents - therapeutic use (1072) 1072
transplantation (1052) 1052
survival (1023) 1023
young adult (1006) 1006
radiotherapy (997) 997
antineoplastic agents - adverse effects (972) 972
recurrence (957) 957
child, preschool (929) 929
risk factors (874) 874
analysis (864) 864
research (854) 854
leukemia, myeloid, acute - drug therapy (850) 850
medicine & public health (849) 849
cisplatin (843) 843
cytarabine - administration & dosage (832) 832
cyclophosphamide - administration & dosage (830) 830
trial (828) 828
health aspects (821) 821
time factors (782) 782
hematology, oncology and palliative medicine (781) 781
animals (779) 779
leukemia (757) 757
prospective studies (744) 744
pharmacology & pharmacy (730) 730
doxorubicin - administration & dosage (703) 703
etoposide - administration & dosage (693) 693
apoptosis (688) 688
surgery (686) 686
fluorouracil - administration & dosage (670) 670
lung neoplasms - drug therapy (657) 657
dose-response relationship, drug (649) 649
vincristine - administration & dosage (635) 635
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (629) 629
infant (624) 624
carcinoma (611) 611
antineoplastic agents - administration & dosage (603) 603
children (588) 588
cisplatin - adverse effects (588) 588
acute myeloid leukemia (585) 585
toxicity (584) 584
immunology (567) 567
patients (565) 565
drug therapy (564) 564
stem-cell transplantation (554) 554
acute myelogenous leukemia (543) 543
salvage therapy (543) 543
acute myeloid-leukemia (541) 541
stem cells (535) 535
neutropenia - chemically induced (530) 530
clinical trials (526) 526
cyclophosphamide (503) 503
hematopoietic stem cell transplantation (496) 496
leukemia, myeloid, acute - mortality (496) 496
article (495) 495
pediatrics (480) 480
tumors (480) 480
disease progression (478) 478
cyclophosphamide - adverse effects (475) 475
kaplan-meier estimate (475) 475
carcinoma, squamous cell - drug therapy (455) 455
antineoplastic agents (450) 450
induction therapy (443) 443
transplantation, autologous (443) 443
phase-ii (441) 441
breast neoplasms - drug therapy (439) 439
remission (437) 437
randomized-trial (433) 433
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10736) 10736
Japanese (248) 248
Chinese (173) 173
French (79) 79
German (77) 77
Russian (63) 63
Spanish (48) 48
Polish (19) 19
Hungarian (17) 17
Italian (7) 7
Czech (5) 5
Dutch (4) 4
Portuguese (3) 3
Serbian (3) 3
Ukrainian (3) 3
Icelandic (2) 2
Bulgarian (1) 1
Hebrew (1) 1
Korean (1) 1
Norwegian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 11, pp. 1509 - 1520
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Infection - chemically induced | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 6, pp. 744 - 751
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2013, Volume 31, Issue 7, pp. 853 - 859
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 874 - 885
Summary Background Relapsed multiple myeloma has no standard treatment, and the role of autologous stem-cell transplantation (ASCT) has not been fully defined.... 
Hematology, Oncology and Palliative Medicine | MAINTENANCE | SUPERIORITY | BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE | IMPACT | METAANALYSIS | ONCOLOGY | CLINICAL-TRIALS | LENALIDOMIDE | SALVAGE THERAPY | INDUCTION | MARROW TRANSPLANTATION | Recurrence | Cyclophosphamide - administration & dosage | Peripheral Nervous System Diseases - chemically induced | Consolidation Chemotherapy - methods | Humans | Middle Aged | Pyrazines - administration & dosage | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Antineoplastic Agents, Alkylating - administration & dosage | Cyclophosphamide - adverse effects | Multiple Myeloma - therapy | Time Factors | Adult | Female | Boronic Acids - administration & dosage | Neutropenia - chemically induced | Doxorubicin - administration & dosage | Bortezomib | Dexamethasone - administration & dosage | Proportional Hazards Models | Thrombocytopenia - chemically induced | Disease Progression | Induction Chemotherapy - adverse effects | Retreatment | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Aged | Multiple Myeloma - genetics | Stem Cell Transplantation - adverse effects | Care and treatment | Relapse | Multiple myeloma | Clinical trials | Transplantation | Diseases | Cyclophosphamide | Chemotherapy | Hospitals | Stem cells | Dosage and administration | Product development | Cancer
Journal Article
Annals of Oncology, ISSN 0923-7534, 03/2018, Volume 29, Issue 3, pp. 731 - 736
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 809 - 818
Journal Article
Journal Article
BMC CANCER, ISSN 1471-2407, 03/2019, Volume 19, Issue 1, pp. 287 - 7
BackgroundPrimary central nervous system lymphoma (PCNSL) is a diffuse large B-cell lymphoma (DLBCL) confined to the central nervous system (CNS) with rising... 
1ST-LINE TREATMENT | CHEMOIMMUNOTHERAPY | PROGNOSIS | METHOTREXATE | High-dose chemotherapy (HDT) | Primary central nervous system lymphoma (PCNSL) | Elderly patients | INTERNATIONAL EXTRANODAL LYMPHOMA | Autologous stem cell transplantation (ASCT) | RANDOMIZATION | ONCOLOGY | RECURRENT PRIMARY CNS | QUALITY-OF-LIFE | RADIOTHERAPY | NERVOUS-SYSTEM LYMPHOMA | Thiotepa - therapeutic use | Lymphoma, Large B-Cell, Diffuse - drug therapy | Cytarabine - therapeutic use | Humans | Antineoplastic Protocols | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Central Nervous System Neoplasms - therapy | Cytarabine - adverse effects | Methotrexate - therapeutic use | Combined Modality Therapy - adverse effects | Induction Chemotherapy - adverse effects | Methotrexate - adverse effects | Rituximab - therapeutic use | Lymphoma, Large B-Cell, Diffuse - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Progression-Free Survival | Hematopoietic Stem Cell Transplantation - adverse effects | Transplantation, Autologous - adverse effects | Aged | Central Nervous System Neoplasms - drug therapy | Rituximab - adverse effects | Thiotepa - adverse effects | Chemotherapy | Usage | Care and treatment | Nervous system cancer | Stem cells | Aged patients | Transplantation | Diagnosis | Health aspects | Cancer
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2016, Volume 76, Issue 3, pp. 432 - 440.e17
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 803 - 811
Summary Background Head and neck cancers positive for human papillomavirus (HPV) are exquisitely radiosensitive. We investigated whether chemoradiotherapy with... 
Hematology, Oncology and Palliative Medicine | TRIAL | SURVIVAL | ORGAN PRESERVATION | THERAPY | ONCOLOGY | POSITIVE HEAD | RISK | LOCALLY ADVANCED HEAD | RADIATION | NECK-CANCER | CHEMOTHERAPY | Chemoradiotherapy - adverse effects | Follow-Up Studies | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Response Evaluation Criteria in Solid Tumors | Oropharyngeal Neoplasms - pathology | Carcinoma, Squamous Cell - radiotherapy | Human papillomavirus 16 | Neoplasm Metastasis | Leukopenia - chemically induced | Deglutition Disorders - etiology | Papillomavirus Infections - virology | Neutropenia - chemically induced | Paclitaxel - administration & dosage | Radiotherapy Dosage | Oropharyngeal Neoplasms - drug therapy | Papillomavirus Infections - complications | Carboplatin - administration & dosage | Oropharyngeal Neoplasms - radiotherapy | Survival Rate | Neoplasm Recurrence, Local - diagnosis | Oropharyngeal Neoplasms - virology | Induction Chemotherapy - adverse effects | Disease-Free Survival | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mucositis - etiology | Carcinoma, Squamous Cell - secondary | Aged | Neoplasm Staging | Papillomaviruses | Carcinoma | Radiotherapy | Papillomavirus infections | Radiation | Cancer | Medical research | Chemotherapy | Analysis | Medicine, Experimental
Journal Article